NIH Guide: Weekly Index for January 24, 2020

Funding Opportunities

• Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)
  (PAR-20-092)
  National Institute on Drug Abuse
  Application Receipt Date(s): Applications will be accepted on a rolling basis, beginning on February 24 , 2020 .
• Harmonization of Alzheimers Disease and Related Dementias (AD/ADRD) Genetic, Epidemiologic, and Clinical Data to Enhance Therapeutic Target Discovery (U24 Clinical Trial Not Allowed)
  (PAR-20-099)
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is May 25, 2020.
• Genomic Community Resources (U24 Clinical Trial Not Allowed)
  (PAR-20-100)
  National Human Genome Research Institute
  National Cancer Institute
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): May 25, 2023
• Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed)
  (PAR-20-101)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Cancer Institute
  National Eye Institute
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): May 27, 2020, May 27, 2021, May 27, 2022,
• HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional)
  (RFA-AT-20-004)
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  Office of Behavioral and Social Sciences Research
  National Institute on Minority Health and Health Disparities
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): March 30, 2020, No late applications will be accepted for this Funding Opportunity Announcement.
• Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
  (RFA-CA-20-007)
  National Cancer Institute
  Application Receipt Date(s): June 9, 2020; November 18, 2020
• Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
  (RFA-CA-20-008)
  National Cancer Institute
  Application Receipt Date(s): June 9, 2020; November 18, 2020
• Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
  (RFA-CA-20-009)
  National Cancer Institute
  Application Receipt Date(s): June 09, 2020; November 18, 2020
• Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
  (RFA-CA-20-010)
  National Cancer Institute
  Application Receipt Date(s): June 09, 2020; November 18, 2020
• Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)
  (RFA-CA-20-011)
  National Cancer Institute
  Application Receipt Date(s): June 9, 2020; November 18, 2020
• Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)
  (RFA-CA-20-012)
  National Cancer Institute
  Application Receipt Date(s): June 09, 2020; November 18, 2020
• Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)
  (RFA-CA-20-013)
  National Cancer Institute
  Application Receipt Date(s): June 09 2020; November 18, 2020
• HIV/AIDS and the Tumor Niche (U54 Clinical Trial Not Allowed)
  (RFA-CA-20-016)
  National Cancer Institute
  Application Receipt Date(s): July 15, 2020
• Urology Centers Program Interactions Core (U24 Clinical Trial Not Allowed)
  (RFA-DK-19-034)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): March 31, 2020 No late applications will be accepted for this Funding Opportunity Announcement
• Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers (Collaborative U01 Clinical Trial Required)
  (RFA-DK-20-501)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute on Aging
  National Cancer Institute
  Application Receipt Date(s): April 22, 2020
• Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Biostatistics Research Center (BRC) (Collaborative U01 Clinical Trial Required)
  (RFA-DK-20-502)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute on Aging
  National Cancer Institute
  Application Receipt Date(s): April 22, 2020
• Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) (U18) Clinical Trials Not Allowed
  (RFA-FD-20-012)
  Food and Drug Administration
  Application Receipt Date(s): March 27, 2020 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Building an Integrated Laboratory System to Advance the Safety of Human and Animal Food (U18) Clinical Trial Not Allowed
  (RFA-FD-20-013)
  Food and Drug Administration
  Application Receipt Date(s): March 23, 2020 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Conduct Studies to Establish More Targeted Durations of Use for Certain Approved Antimicrobial New Animal Drugs in Food Animals (U01) Clinical Trials Optional
  (RFA-FD-20-025)
  Food and Drug Administration
  Application Receipt Date(s): May 1, 2020, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• HEAL Initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development (R61/R33 - Clinical Trial Not Allowed)
  (RFA-HL-20-031)
  National Heart, Lung, and Blood Institute
  National Institute on Drug Abuse
  Application Receipt Date(s): March 24, 2020 No late applications will be accepted for this Funding Opportunity Announcement.
• HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
  (RFA-NS-20-028)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Nursing Research
  National Center for Complementary and Integrative Health
  Office of Behavioral and Social Sciences Research
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): March 24, 2020